The present invention relates to an arterial sheath introducer. More specifically, the present invention relates to an arterial sheath introducer intended to facilitate introduction of interventional catheter devices through the skin and into the arterial system.
Currently, vascular introducer sheaths used to access radial or femoral arteries suffer from various limitations. These include buckling or “roll-back” of the very distal tip upon entry into the skin. This is caused by a poor or abrupt transition or step between the introducer tip and the dilator that is inside the introducer to provide a transition from the guidewire to the sheath. Roll-back can also be caused by inadequate mechanical structure of the sheath tip.
Another limitation of current vascular introducer sheaths is the overall diameter of the introducer can be too large, such that excessive bleeding upon removal and/or arterial spasm during use can be caused. This limitation can be due to excessive wall thickness of the introducer related to current introducer construction methods.
A further limitation of current introducer is kinking or buckling during manipulation, insertion, or withdrawal of the catheter through the sheath or due to excessive cutaneous tissue thickness. The kinking and buckling of the introducer can be inherent in the construction and design of currently available introducer.
Embodiments of the invention include a radial artery catheter introducer sheath for introducing interventional catheters to the vasculature comprising: a main tubular shaft comprising a distal tip, a proximal end, an inner layer, a main structural layer and an outer layer; wherein the inner layer comprises one or more layers of polymer with a thickness of 0.001-0.005 inches, the main structural layer comprises one or more metallic helically wound multi-filar wires with a wall thickness of 0.0015 inches to 0.010 inches; wherein the outer layer comprises an outer polymer jacket that at least partially covers the inner layer at the distal tip, and the outer polymer jacket is coupled to the main structural layer; wherein the outer polymer jacket has a thickness of 0.001 inches to 0.010 inches; wherein the distal tip comprises 2 or more layers, these layers formed of the outer polymer and inner polymer, and the distal tip has a length of 0.05 inches and 0.30 inches.
In an embodiment, the main tubular shaft can have an outer diameter of 0.060 inches to 0.160 inches. The main tubular shaft can comprise an inner polymer layer, a main structural layer comprised of multi-filar wires that have been swaged into a rectangular cross-section and covered with a metallic wire braid and an outer polymer jacket. The distal tip can also comprise two or more layers, such as a layer of PTFE and a layer of Pebax.
This summary is an overview of some of the teachings of the present application and is not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details are found in the detailed description and appended claims. Other aspects will be apparent to persons skilled in the art upon reading and understanding the following detailed description and viewing the drawings that form a part thereof, each of which is not to be taken in a limiting sense. The scope of the present invention is defined by the appended claims and their legal equivalents.
The invention may be more completely understood in connection with the following drawings, in which:
While the invention is susceptible to various modifications and alternative forms, specifics thereof have been shown by way of example and drawings, and will be described in detail. It should be understood, however, that the invention is not limited to the particular embodiments described. On the contrary, the intention is to cover modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
The embodiments of the present invention described herein are not intended to be exhaustive or to limit the invention to the precise forn1s disclosed in the following detailed description. Rather, the embodiments are chosen and described so that others skilled in the art can appreciate and understand the principles and practices of the present invention.
All publications and patents mentioned herein are hereby incorporated by reference. The publications and patents disclosed herein are provided solely for their disclosure. Nothing herein is to be construed as an admission that the inventors are not entitled to antedate any publication and/or patent, including any publication and/or patent cited herein.
The device of this invention solves the problems associated with current vascular introducer sheaths by providing novel improved design, construction and materials.
In an embodiment, the structural layer 1 can comprise 12 or more filars. In an embodiment, the structural layer 1 can comprise 18 or fewer filars. In an embodiment, the multi-filar structure can be swaged such that each wire has a rectangular cross-section, such that it can result in a very close fitting wire matrix between adjacent wires. The multi-filar structure can comprise non-swaged wires. The multi-filar structure can comprise a wire with a round (such as circular, oval, or elliptical) cross-section. The multi-filar structure can comprise a wire with a square or rectangular cross-section. The multi-filar structure can comprise welded ends. The multi-filar structure can comprise a PTFE coating. In an embodiment, the multi-filar wires can comprise a PTFE coating prior to forming the multi-filar structure.
In an embodiment, the structural layer 1 can define a center lumen, such as to allow an inner dilator to pass through the introducer 100. The structural layer 1 can have a thickness of 0.0015 inches or more. The structural layer 1 can have a thickness of 0.003 inches or less. In an embodiment, the structural layer 1 can have a thickness of 0.010 inches or less. The structural layer 1 can provide a significant improvement in mechanical integrity of the sheath compared to existing introducer sheaths with respect to kinking, buckling, flexibility, radial strength and maintaining cross-sectional circularity of the sheath.
The introducer 100 can include a distal end and a proximal end 6. In an embodiment, the distal end of the introducer 100 can be curved, such as to conform to a portion of a patient's anatomy. In an embodiment, the structural layer can be curved to the desired shape and heat processed such that the structural layer holds the desired curve shape.
The introducer 100 can further comprise an outer layer 2. The outer layer can comprise an outer polymer jacket. The outer polymer jacket can substantially cover the outside surface of the structural layer 1. The outer polymer jacket can comprise one or more of the following: PTFE, Pebax, nylon and Polyurethane. In an embodiment, the outer polymer jacket 2 comprises one or more layers or segments of different polymers. In an embodiment, the outer polymer jacket comprises two or more layers of Pebax. The outer polymer jacket can comprise or be coated with a hydrophilic polymer. The outer polymer jacket can be coupled to the structural layer 1, such as by thermal polymer heat-shrinking or reflow. Heat shrinking the outer polymer jacket can allow the outer polymer jacket 2 to be formed tightly onto the structural layer 1. In an embodiment, the outer polymer jacket can have a thickness of 0.001 inches or more. In an embodiment, the outer polymer jacket can have a thickness of 0.003 inches or less. In an embodiment, the outer polymer jacket can have a thickness of 0.010 inches or less.
The introducer 100 can further comprise an inner layer 7. The inner layer 7 can comprise an inner polymer jacket. The inner polymer jacket can substantially cover a surface of the structural layer 1, such as the inner surface. The inner polymer jacket can comprise one or more of the following: PTFE, Pebax, nylon and Polyurethane. In an embodiment, the inner polymer jacket comprises one or more layers or segments of different polymers. In an embodiment, the inner polymer jacket comprises two or more layers of Pebax. The inner polymer jacket can comprise or be coated with a hydrophilic polymer. The inner polymer jacket can be coupled to the structural layer 1, such as by thermal polymer reflow. In an embodiment, the inner polymer jacket can have a thickness of 0.001 inches or more. In an embodiment, the inner polymer jacket can have a thickness of 0.005 inches or less. In an embodiment, the inner polymer jacket can have a thickness of 0.010 inches or less.
In an embodiment, the lamination of the structural layer 1, the outer layer 2, and the inner layer 7 does not include fusion of the outer layer 2 and the inner layer 7. In an embodiment, the inner layer 7 and the outer layer 2 can be fused between and through the structural layer 1. In other implementations the outer layer and the inner layer are not fused together.
In some implementations the material forming the introducer, taken along a cross section of the introducer perpendicular to the central axis of the introducer, is from 40 to 60 percent metal. In other implementations the material forming the introducer, taken along a cross section of the introducer perpendicular to the central axis of the introducer, is from 20 to 60 percent metal. Alternatively the material forming the introducer, taken along a cross section of the introducer perpendicular to the central axis of the introducer, is greater than 20 percent metal.
The introducer 100 can further comprise a distal tip 3. The distal tip 3 can be tapered, such that the portion of the distal tip 3 closer to the proximal end 6 of the introducer 100 has a larger outer diameter than the distal end of the distal tip 3. The outer diameter of the distal end of the distal tip 3 can be configured to closely hug the outer diameter of an inner dilator.
The length of the distal tip 3 can be at least 0.05 inches. In an embodiment, the length of the distal tip 3 is 0.30 inches or less.
The distal tip 3 can comprise an inner tip layer and an outer tip layer. The inner tip layer can comprise PTFE, and the outer tip layer can comprises Pebax. The distal tip 3 can comprise a gold coating. In an embodiment, the thickness of the gold coating is 0.5 mm or more. In an embodiment, the thickness of the gold coating is 2 mm or less. The distal tip 3 can comprise a composite of a thin sheath jacket layer on the inside of the tip and a reflowed polymer on the outside. A distal tip 3 comprising such a composite can results in a very close fitting (non-abrupt) transition from the inner dilator to the introducer 100, thus reducing potential introducer tip damage such as “roll-back” or buckling. The main tubular shaft can be coupled to the hemostatis valve 4.
As shown in
It should be noted that, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to a composition containing “a compound” includes a mixture of two or more compounds. It should also be noted that the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It should also be noted that, as used in this specification and the appended claims, the phrase “configured” describes a system, apparatus, or other structure that is constructed or configured to perform a particular task or adopt a particular configuration to. The phrase “configured” can be used interchangeably with other similar phrases such as arranged and configured, constructed and arranged, constructed, manufactured and arranged, and the like.
All publications and patent applications in this specification are indicative of the level of ordinary skill in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated by reference.
The invention has been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope of the invention.
This application claims the benefit of U.S. Provisional Application No. 61/840,764, filed Jun. 28, 2013, the content of which is herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
5938587 | Taylor et al. | Aug 1999 | A |
5951539 | Nita | Sep 1999 | A |
6197014 | Samson | Mar 2001 | B1 |
6689120 | Gerdts | Feb 2004 | B1 |
8317772 | Jansen | Nov 2012 | B2 |
9937321 | Welch | Apr 2018 | B2 |
10702674 | Ganske et al. | Jul 2020 | B2 |
20100331936 | Perrey et al. | Dec 2010 | A1 |
20130172851 | Shimada et al. | Jul 2013 | A1 |
20140336572 | Heisel et al. | Nov 2014 | A1 |
20140343537 | Eversull et al. | Nov 2014 | A1 |
20160101261 | Kugler et al. | Apr 2016 | A1 |
20160151605 | Welch et al. | Jun 2016 | A1 |
20170095640 | Rogers | Apr 2017 | A1 |
20170252535 | Ganske et al. | Sep 2017 | A1 |
Number | Date | Country |
---|---|---|
105579091 | May 2016 | CN |
105579091 | Apr 2020 | CN |
1068876 | Jan 2001 | EP |
3013404 | Apr 2020 | EP |
WO-2001010492 | Feb 2001 | WO |
WO-2005072806 | Aug 2005 | WO |
WO-2005072806 | Feb 2006 | WO |
WO-2013003835 | Jan 2013 | WO |
WO-2014189828 | Nov 2014 | WO |
WO-2014210427 | Dec 2014 | WO |
WO-2017201280 | Nov 2017 | WO |
Entry |
---|
“Chinese Application Serial No. 201480046445.1, Office Action dated Jun. 5, 2018”, w/ English translation, 12 pgs. |
“U.S. Appl. No. 14/900,729, Examiner Interview Summary filed Nov. 17, 2017”, 1 pgs. |
“U.S. Appl. No. 14/900,729, Non Final Office Action dated May 31, 2017”, 20 Pgs. |
“U.S. Appl. No. 14/900,729, Notice of Allowance dated Nov. 16, 2017”, 10 pgs. |
“U.S. Appl. No. 14/900,729, Response filed on Oct. 2, 2017 to Non Final Office Action dated May 31, 2017”, 17 pgs. |
“European Application Serial No. 14818501.0, Extended European Search Report dated Feb. 2, 2017”, 11 pgs. |
“European Application Serial No. 14818501.0, Response filed Aug. 11, 2016 to Communication pursuant to Rules 161(1) and 162 EPC dated Feb. 12, 2016”, 7 pgs. |
“European Application Serial No. 14818501.0, Response filed Sep. 4, 2017 to Extended European Search Report dated Feb. 2, 2017”, 7 pgs. |
“International Application Serial No. PCT/US2014/044519, International Preliminary Report on Patentability dated Jan. 7, 2016”, 13 pgs. |
“International Application Serial No. PCT/US2014/044519, International Search Report dated Oct. 21, 2014”, 4 pgs. |
“International Application Serial No. PCT/US2014/044519, Written Opinion dated Oct. 21, 2014”, 11 pgs. |
“International Application Serial No. PCT/US2017/033319, International Search Report dated Aug. 16, 2017”, 2 pgs. |
“International Application Serial No. PCT/US2017/033319, Written Opinion dated Aug. 16, 2017”, 7 pgs. |
“U.S. Appl. No. 15/598,114, Non Final Office Action dated Jun. 25, 2019”, 16 pgs. |
“Chinese Application Serial No. 201480046445.1, Office Action dated Sep. 29, 2019”, w/ English Translation, 7 pgs. |
“Chinese Application Serial No. 201480046445.1, Response filed May 29, 2019 to Office Action dated Mar. 14, 2019”, w/ English Claims, 15 pgs. |
“Chinese Application No. 201480046445.1, Office Action dated Mar. 14, 2019”, W/ English Translation, 9 pgs. |
“Chinese Application Serial No. 201480046445.1, Response filed Dec. 20, 2018 to Office Action dated Jun. 5, 2018”, w/ English Claims, 7 pgs. |
“European Application Serial No. 14818501.0, Communication Pursuant to Article 94(3) EPC dated Dec. 6, 2018”, 7 pgs. |
“European Application Serial No. 14818501.0, Response Filed Apr. 16, 2019 to Communication Pursuant to Article 94(3) EPC dated Dec. 6, 2018”, 10 pgs. |
“Chinese Application Serial No. 201480046445.1, Response filed Dec. 13, 2019 to Office Action dated Sep. 29, 2019”, with English claims, 15 pages. |
“U.S. Appl. No. 15/598,114, Notice of Allowance dated Apr. 8, 2020”, 8 pgs |
“U.S. Appl. No. 15/598,114, Response filed Dec. 23, 2019 to Non Final Office Action dated Jun. 25, 2019”, 17 pages. |
U.S. Appl. No. 16/889,188, filed Jun. 1, 2020, Braided Catheter Assemblies. |
“Canadian Application Serial No. 2,919,458, Office Action dated Jul. 8, 2020”, 4 pages. |
Number | Date | Country | |
---|---|---|---|
20180243534 A1 | Aug 2018 | US |
Number | Date | Country | |
---|---|---|---|
61840764 | Jun 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14900729 | US | |
Child | 15904026 | US |